Supplement: MilliporeSigma Sees Opportunity in Continuous Processing
From the GEN Sounds of Science Podcast
Why CAR-T Therapies Don’t Work for Everyone Yet
Selecting the Best Type of T Cells for CAR-T May be Key to the Overall Efficacy of the Therapies
Cell-Centered: Scientists Embrace Cell-Replacement Therapy for Type 1 Diabetes
Forming Beta Cells from Stem Cells
GEN Roundup: Multiplex Immunoassays Bring the Array, Not the Disarray
Get Multiplex Immunoassay Advice from GEN's Expert Panel
For full access to this article login to GEN Select now.
The Tragedy of Destructive Acquisition
A Poorly Planned “Purchase of Choice” May Lead to Less-Than-Choice Outcomes
- In this column, in the December 1, 2012 and August 1, 2013 issues, I provided evidence that growth of the biotech industry has been enhanced by creative acquisition—the acquisition of successful firms by larger firms at premium market valuations. Creative acquisition, however, has a dark side that could be ...
Not registered yet? Please fill out the form below and enjoy complimentary access to this and an exclusive collection of premium content and personalization features as a GEN Select insider. Learn More.
Get GEN Select Access Now
- Do not put any letters or characters here if you are not a spy program.